Percutaneous Coronary Intervention Registry FRIBOURG

计划入组 3,000 人 · 首次发布于 2019 年 12 月 4 日

Colchicine in Percutaneous Coronary Intervention

计划入组 714 人 · 首次发布于 2015 年 11 月 1 日

Kitasato PCI Registry

计划入组 4,500 人 · 首次发布于 2022 年 4 月 4 日

Abciximab

Bivalirudin(Angiomax)

C₉₈H₁₃₈N₂₄O₃₃ · Rx

Cangrelor(Kengreal, Kengrexal)

C₁₇H₂₅Cl₂F₃N₅O₁₂P₃S₂

EFFECTIVE INTERVENTION

Gambia The

Oregon Research Behavioral Intervention Strategies, Inc.

United States

InspireMD

TCT 2025 Unveils 28 Late-Breaking Cardiovascular Trials Featuring Novel Drug-Eluting Technologies and AI-Enabled Diagnostics

Supira Medical Raises $120M in Series E Funding, Completes SUPPORT I Enrollment for Novel Cardiac Support Device

Supira Medical Receives FDA Approval for SUPPORT II Pivotal Trial of Next-Generation Percutaneous Ventricular Assist Device